Pharmaceutical drug development embodies the intricate journey of transforming scientific discoveries into safe and effective medications. It is an intricate process that integrates multidisciplinary expertise, spanning from initial research to clinical trials and eventual regulatory approval.
At its inception, drug development involves identifying potential compounds through rigorous research, often driven by a deep understanding of biological mechanisms and disease pathways. These candidates then undergo preclinical testing to assess their safety, efficacy, and potential side effects. Upon successful preclinical evaluations, promising candidates advance to clinical trials, where they are meticulously tested on human subjects. This phase involves rigorous testing for safety, dosage determination, and efficacy across diverse patient populations. Clinical trials are pivotal, providing critical data that informs decisions on the drug's viability.
Post-approval, ongoing monitoring ensures the drug's safety and effectiveness in real-world settings. Continuous research and development efforts persist to refine existing medications and discover novel therapies, perpetuating the cyclical nature of pharmaceutical drug development.
In essence, pharmaceutical drug development is an intricate dance between scientific innovation, ethical considerations, and regulatory scrutiny, ultimately aimed at delivering safe, efficacious, and transformative medicines to improve global health.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India